The HMGCS2 gene helps the liver make ketones, an emergency fuel your body uses during fasting, illness, or long gaps between meals. If this gene does not work properly, the body may struggle to use fat for energy and can develop low blood sugar with unusually low ketone levels. People with pathogenic variants in the HMGCS2 gene may have episodes of sleepiness, vomiting, seizures, or liver problems, often in infancy or early childhood.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes give the directions for building proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in LearnHub.
Overview
HMGCS2Gene function
What if the gene works
The HMGCS2 gene helps the liver make ketones, an energy source used during fasting. This supports the brain and other tissues when sugar from food is low.
Risk
What if the gene does not work
Changes in the HMGCS2 gene can impair ketone production, especially during fasting or illness. Milder to more severe variants may cause episodes of low blood sugar with low ketones, vomiting, sleepiness, and liver problems, with timing and severity varying.
Treatment
What does that mean for your treatment
For people with pathogenic or loss-of-function variants in the HMGCS2 gene, treatment centers on preventing low blood sugar and metabolic crises during fasting. Care plans usually emphasize regular carbohydrate intake and quick use of glucose during illness. Ketogenic diets and prolonged fasting are usually avoided, and IV dextrose may be used during acute episodes. No HMGCS2-specific drug is currently established.
Conditions associated with HMGCS2
Gene function
What if the gene works
When food intake drops between meals or overnight, your liver shifts to a backup fuel plan. The HMGCS2 gene helps make ketones, small fuel molecules your body can use when glucose is less available. This supports how your body makes ketones during fasting, longer exercise, and low carbohydrate intake.
Inside liver cell mitochondria (the parts of cells that help make energy), this gene helps join small pieces from fat into HMG-CoA. That is a key early step in making ketone bodies.
When glucose supply is lower, HMGCS2 supports the body’s shift from sugar use toward fuel from fat. The ketones made through this pathway can be used by the brain, heart, and muscles.
By supporting ketone production, this gene helps the liver release an alternative fuel into the bloodstream. This helps keep energy available between meals, during sleep, and with longer exercise.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In HMGCS2 deficiency, variants in the HMGCS2 gene can change the enzyme's shape, make it unstable, or sharply reduce its activity inside mitochondria (the energy-making parts of cells). This is how HMGCS2 gene variants affect ketone production, especially during fasting or illness. Some variants leave partial activity, while more severe variants that cut the protein short or disrupt the gene's message may leave little or none, which can influence how early and how strongly episodes appear.
How variants are linked to conditions
Pathogenic variants in the HMGCS2 gene cause mitochondrial HMG-CoA synthase deficiency, a rare inherited condition. In people with this diagnosis, symptoms often appear during fasting or illness and can include episodes of low blood sugar, vomiting, unusual sleepiness, and liver problems. The main condition linked to HMGCS2 gene variants is this well-established ketone production condition, rather than a broad range of unrelated diseases.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. There are cases, however, where one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in both copies of the HMGCS2 gene, risk is mostly set by genetics. Long fasting, stomach bugs or other illnesses, vomiting, and sometimes heavy exercise can trigger dangerous low-blood-sugar episodes, especially in babies and young children. There is not enough evidence to say lifestyle changes lower the underlying genetic risk.
Inheritance of HMGCS2 variants
Variants in the HMGCS2 gene are inherited in an autosomal recessive pattern. This means a person usually develops HMGCS2 deficiency only when they inherit two disease-causing variants, one from each parent. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either variant. When people ask how variants of the HMGCS2 gene are inherited, this is the well-established pattern.
What does my HMGCS2 result mean for my family?
For families with an HMGCS2-related condition, parents are often healthy carriers of the changed gene. Brothers and sisters may also have the condition or be carriers, even if they seem well day to day. More distant relatives, such as aunts, uncles, and cousins, may also carry the same gene change, so a family result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for HMGCS2 variants usually uses a blood sample or saliva sample to read the HMGCS2 gene and look for variants linked to HMGCS2 deficiency. It may be done as a single gene test or as part of a broader metabolic panel. Results can confirm a diagnosis, clarify carrier status, or identify a known family variant.
When should I consider getting a genetic test?
You might consider HMGCS2 genetic testing if a child has repeated episodes of very low blood sugar during fasting or illness, especially when the body is not making enough ketones, its usual backup fuel. Testing can also make sense if this condition has already been diagnosed in a close family member.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Variants in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are both more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the HMGCS2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, new symptoms, or whether a treatment fits your overall health are best discussed with your doctor.
History
Research on HMGCS2 grew out of wider work on ketone body metabolism in the mid to late 20th century, when scientists realized that similar enzyme activities came from distinct forms in different parts of the cell. From these first observations, research expanded steadily, and by the early 1990s investigators had isolated and described the human HMGCS2 gene as separate from the related cytosolic form. This helped clarify earlier biochemical findings from fasting and liver studies. In the years that followed, reports of families with HMGCS2 variants linked the gene to a recognizable inherited metabolic condition. Over time, descriptions became more precise as DNA sequencing allowed clinicians and researchers to connect specific variants with episodes of illness during fasting or infection.